Postoperative leaks pose a significant risk to patients undergoing sleeve gastrectomy (SG).1 Currently, self-expandable metal stent (SEMS) placement is the mainstay of the treatment of early bariatric leaks.2 The stent works by covering the orifice of the fistula and also shaping the stomach and promoting a distal dilation, treating downstream obstruction.3,4 The overall success rate of stent use was 72.8%, with a migration rate of 28.2%.2 Recently, a newer stent, the megastent, has also emerged as an interesting option because its long and large shape adequately fits the tortuous anatomy of the SG, demonstrating superior results in comparison with esophageal stents in the management of sleeve leaks; however, serious adverse events may arise.